VIVOLABS, the molecular biology laboratory of the VIVO group, chose Genomcore’s SaaS solution for data management and automated, streamlined NGS data analysis. Genomcore provided the scalable and secure cloud-based infrastructure to rapidly scale and increase laboratory efficiency.
HOPE by SOLTI is a leading real-world clinical practice study in Spain that assesses the impact of using comprehensive genomic data on treatment decision-making for patients with locally advanced or metastatic breast cancer. It is highly relevant for its patient empowerment approach that has exceeded participation expectations.
DIPCAN aims to change clinical practice in the area of oncology by combining clinical, imaging, anatomopathological, and genomic data to identify certain patients who could be more likely to better respond to treatment. Genomcore provides its technological framework to process and integrate all datasets into a single database for AI model development.
Made of Genes is an innovative molecular health service that uses genetic, blood, and health questionnaire data to offer personalized care recommendations. Backed by Genomcore, their low-code platform allows for easy integration with health providers, turning scientific knowledge into actionable precision health insights.
The AGATA study is the first genomic screening platform for advanced breast cancer ever attempted in Spain. By this molecular platform SOLTI aimed to increase the likelihood of a patient being included in a targeted clinical trial based on the tumor molecular profiling. Genomcore provided a secure and compliant federated platform to store and analyze the clinical and genomic data within the project.
In this project, wearables were used to monitor physical activity and improve the health and independence of citizens over 65 in Andorra. Genomcore’s multi-modal platform allowed data interoperability, including wearable data retrieval and integration, data storage and analytics for precision health analyses.